HSBC Continues to Sell Non-Core Assets

Antonio Losada, President and CEO of HSBC Latin America and the Caribbean

HSBC is selling businesses in four South American countries as it carries on its plan of leaving what it regards as less promising markets.

The deal is still subject to regulatory approval but HSBC has reported the sale of its affiliates in Uruguay, Colombia, Peru and Paraguay to the Colombian group Gilinski, an operation involving 400 million dollars.

HSBC has now announced 11 deals to sell or close operations that it does not consider central to its growth plans.

Speaking about this latest deal, Antonio Losada, President and CEO of HSBC Latin America and the Caribbean, said: “We are pleased to have reached this agreement with Banco GNB Sudameris as we seek to focus on our operations where we see the greatest potential for sustainable growth for HSBC.

The combined the banks being sold have 62 branches across the four countries and assets worth $4.4bn

Before the operation is completed Banco GNB Sudameris must obtain the approval from the regulatory agencies in the four countries. The group said it expects the operations in Colombia and Peru will be closed in the last quarter of 2012, and in Uruguay and Paraguay in the first quarter of 2013.

Another bank on sale is Lloyds, which has been in Uruguay since 1863. Apparently there are ongoing talks with the local affiliate of the Swiss Banque Heritage.

CFI

Recent Posts

Digital Health’s Q1 2025 Unicorn Baby Boom: Investors Bet Big on Innovation

The first quarter of 2025 saw an unprecedented rise in the valuation of digital health…

4 hours ago

From Dubai Chocolate to AI: The Middle East in Transition

A sweet retail success in Dubai reflects a deeper transformation across the Middle East —…

2 days ago

Cube Labs: Transforming Scientific Discovery into Scalable Healthcare Innovation

Italy-based Cube Labs is redefining healthcare venture building by bridging the gap between academic research…

4 days ago

Filippo Surace: The Visionary Behind Italy’s Healthcare Venture Revolution

From surgeon to life sciences entrepreneur, Filippo Surace is charting a new course for healthcare…

4 days ago

Is the MBA Still Worth It? Weighing Value, ROI, and Leadership Impact

In an era of rapid disruption, does the traditional MBA still hold its weight? We…

1 week ago

Jefferies Trades Lone-Wolf Culture for Team-First Strategy in Bid for Wall Street’s Top Tier

For decades, Jefferies built its reputation as Wall Street’s maverick outpost — the last independent,…

2 weeks ago